Skip to main content

Table 3 Dietary intake of METABO and placebo groups from week 0 through week 8 using 3-day food records

From: Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women

Variable

METABO

Placebo

P

n = 27

n = 18

Value1

(Baseline) Pre-intervention

Mid point

End of study

(Baseline) Pre-intervention

Mid point

End of study

 
 

(Week 0)

(Week 4)

(Week 8)

(Week 0)

(Week 4)

(Week 8)

 

Energy (kcal/d)

1831 ± 491

1889 ± 428

1912 ± 423

1764 ± 482

1913 ± 432

1917 ± 479

0.48, 0.41

Carbohydrate (g/d)

206 ± 78

188 ± 58

188 ± 57

215 ± 94

191 ± 58

202 ± 61

0.94, 0.80

Carbohydrate (%)

46 ± 14

39 ± 6

39 ± 5

48 ± 15

40 ± 6

42 ± 5

0.70, 0.90

Fat (g/d)

54 ± 20

56 ± 17

57 ± 15

52 ± 23

57 ± 13

56 ± 13

0.87, 0.85

Fat (%)

26 ± 7

27 ± 4

27 ± 4

27 ± 10

27 ± 4

27 ± 4

0.98, 0.79

Protein (g/d)

130 ± 66

158 ± 43

162 ± 47

110 ± 50

161 ± 47

150 ± 50

0.77, 0.66

Protein (%)

28 ± 12

34 ± 8

34 ± 7

26 ± 13

34 ± 7

31 ± 6

0.52, 0.99

  1. Values are mean ± SD.
  2. 1P values are for the differences between the two groups, METABO versus placebo at week 4 and week 8, respectively. No significant between group differences at week 4 or week 8 time points were noted using ANCOVA (where the week 0 time points were used as the covariate). Target dietary intake was provided to each subject after baseline 3-day food records (pre-intervention) using the Mifflin-St. Jeor equation plus an activity factor of 1.2 minus 500 kcal/day, with a macronutrient ratio of 40% carbohydrate, 30% fat and 30% protein.